Department of Medical Oncology, University Hospital Jean Minjoz, 25030 Besançon Cedex, France.
Eur J Cancer Prev. 2011 Jan;20 Suppl 1:S16-9. doi: 10.1097/01.cej.0000391565.41383.ba.
In France, mammography screening is offered to women aged between 50 and 74 years. EDIFICE, the iterative nationwide survey, collected data on a national level about consumers utilization of available cancer screening procedures. This analysis compared data from a subset of 241 women aged between 40 and 50 years with that of 488 women aged between 50 and 74 years. Multivariate analysis showed the following significant factors to be linked with screening attendance for women younger than 50 years: age, with a threshold value at 44 years; awareness of the recommended screening period (2 years); consultation within the last 12 months with a general practitioner or a gynaecologist; and long standing local programme for colon cancer screening. Notwithstanding the debate on risk/benefit of breast cancer screening for women in their 40s, we observed more differences with regard to attendance between women aged 40-45 years versus that of 46-74 years than between women aged 40-49 years versus that of 50-74 years. The issue that is unanswered as yet is, do women make a kind of heuristic for starting breast cancer screening, leading them to a threshold choice of 45 years or alternatively to a collective answer of standard age minus 5 years!
在法国,乳腺 X 线筛查面向 50 至 74 岁的女性。EDIFICE 是一项全国性的迭代调查,在国家层面上收集了有关消费者利用现有癌症筛查程序的数据。本分析比较了年龄在 40 至 50 岁的 241 名女性与年龄在 50 至 74 岁的 488 名女性的亚组数据。多变量分析显示,以下显著因素与 50 岁以下女性的筛查参与率有关:年龄,以 44 岁为阈值;对推荐的筛查期(2 年)的认识;在过去 12 个月内与全科医生或妇科医生的咨询;以及长期存在的结肠癌筛查地方计划。尽管关于 40 多岁女性乳腺癌筛查的风险/获益存在争议,但我们观察到,40-45 岁女性与 46-74 岁女性之间的参与差异比 40-49 岁女性与 50-74 岁女性之间的差异更大。目前尚未解决的问题是,女性是否会对开始乳腺癌筛查做出某种启发式决策,导致她们选择 45 岁作为阈值,或者选择标准年龄减去 5 岁作为集体答案!